ClinicalTrials.Veeva

Menu

MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma

N

Nanjing Medical University

Status

Active, not recruiting

Conditions

Gastric Cancer, Gastroesophageal Junction Cancer

Treatments

Diagnostic Test: mpMRI

Study type

Observational

Funder types

Other

Identifiers

NCT06640153
2024-SR-587

Details and patient eligibility

About

Accurate preoperative Siewert classification, precise assessment of the extent of esophageal involvement, and staging is crucial for determining the appropriate surgical approach and achieving negative resection margins. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and computed tomography (CT) in gastroesophageal junction and upper gastric cancers.

Full description

Despite a continuous decline in the incidence of gastric cancer in recent years, the morbidity and mortality rates associated with the gastroesophageal junction and upper gastric cancers remain elevated. Consequently, it is imperative to develop more refined and individualized precision strategies for screening, diagnosis, surgical intervention, and comprehensive treatment. Due to the unique anatomical location, considerable debate exists regarding the critical aspects of its surgical management in clinical practice. Multiparametric MRI offers significant anatomical benefits due to its high soft tissue resolution, and its functional imaging capabilities present promising applications. With advancements in abdominal imaging technology, novel techniques such as high-order diffusion imaging and compressed sensing technology have facilitated high-resolution MRI of the stomach during free breathing, which is now implemented in clinical practice. Prior research has demonstrated that individualized gastric MRI scanning consistently yields superior image quality, and MRI provides greater accuracy than CT in preoperative staging assessments. Nonetheless, the comparative study of MRI and CT in patients with gastroesophageal junction and upper gastric cancers remains to be elucidated.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients with gastric cancer confirmed by preoperative gastroscopic biopsy;
  2. underwent standardized mpMRI and CT examination;
  3. patients with complete postoperative pathological data and pathological results of gastroesophageal Junction or upper gastric adenocarcinoma;

Exclusion criteria

  1. combined with other tumors;
  2. Clinical and imaging data were missing or could not meet the research needs;
  3. the location of lesions could not be determined;

Trial design

100 participants in 1 patient group

Experimental: Gastroesophageal junction or upper gastric adenocarcinoma
Description:
Patients with biopsy verified gastroesophageal junction or upper gastric adenocarcinoma undergo mpMRI in addition to conventional CT imaging
Treatment:
Diagnostic Test: mpMRI

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems